Literature DB >> 16882971

Extensive post-transcriptional regulation of microRNAs and its implications for cancer.

J Michael Thomson1, Martin Newman, Joel S Parker, Elizabeth M Morin-Kensicki, Tricia Wright, Scott M Hammond.   

Abstract

MicroRNAs (miRNAs) are short, noncoding RNAs that post-transcriptionally regulate gene expression. While hundreds of mammalian miRNA genes have been identified, little is known about the pathways that regulate the production of active miRNA species. Here we show that a large fraction of miRNA genes are regulated post-transcriptionally. During early mouse development, many miRNA primary transcripts, including the Let-7 family, are present at high levels but are not processed by the enzyme Drosha. An analysis of gene expression in primary tumors indicates that the widespread down-regulation of miRNAs observed in cancer is due to a failure at the Drosha processing step. These data uncover a novel regulatory step in miRNA function and provide a mechanism for miRNA down-regulation in cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882971      PMCID: PMC1553203          DOI: 10.1101/gad.1444406

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  33 in total

Review 1.  microPrimer: the biogenesis and function of microRNA.

Authors:  Tingting Du; Phillip D Zamore
Journal:  Development       Date:  2005-11       Impact factor: 6.868

2.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

3.  In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes.

Authors:  Wigard P Kloosterman; Erno Wienholds; Ewart de Bruijn; Sakari Kauppinen; Ronald H A Plasterk
Journal:  Nat Methods       Date:  2006-01       Impact factor: 28.547

4.  Facile means for quantifying microRNA expression by real-time PCR.

Authors:  Rui Shi; Vincent L Chiang
Journal:  Biotechniques       Date:  2005-10       Impact factor: 1.993

5.  Post-transcriptional regulation of microRNA expression.

Authors:  Gregor Obernosterer; Philipp J F Leuschner; Mattias Alenius; Javier Martinez
Journal:  RNA       Date:  2006-05-31       Impact factor: 4.942

6.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

7.  Modulation of microRNA processing and expression through RNA editing by ADAR deaminases.

Authors:  Weidong Yang; Thimmaiah P Chendrimada; Qingde Wang; Miyoko Higuchi; Peter H Seeburg; Ramin Shiekhattar; Kazuko Nishikura
Journal:  Nat Struct Mol Biol       Date:  2005-12-20       Impact factor: 15.369

8.  A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.

Authors:  Elisavet Maniataki; Zissimos Mourelatos
Journal:  Genes Dev       Date:  2005-12-15       Impact factor: 11.361

9.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation.

Authors:  Jian-Fu Chen; Elizabeth M Mandel; J Michael Thomson; Qiulian Wu; Thomas E Callis; Scott M Hammond; Frank L Conlon; Da-Zhi Wang
Journal:  Nat Genet       Date:  2005-12-25       Impact factor: 38.330

10.  miRBase: microRNA sequences, targets and gene nomenclature.

Authors:  Sam Griffiths-Jones; Russell J Grocock; Stijn van Dongen; Alex Bateman; Anton J Enright
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

View more
  404 in total

Review 1.  MicroRNAs in renal development.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  Pediatr Nephrol       Date:  2012-06-02       Impact factor: 3.714

2.  miRNAs in human cancer.

Authors:  Xiaomin Zhong; George Coukos; Lin Zhang
Journal:  Methods Mol Biol       Date:  2012

Review 3.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

4.  The Evi1, microRNA-143, K-Ras axis in colon cancer.

Authors:  Jin-Song Gao; Yingjie Zhang; Xiaoli Tang; Lynne D Tucker; Patrick M Tarwater; Peter J Quesenberry; Isidore Rigoutsos; Bharat Ramratnam
Journal:  FEBS Lett       Date:  2011-01-26       Impact factor: 4.124

5.  The enemy within: intronic miR-26b represses its host gene, ctdsp2, to regulate neurogenesis.

Authors:  Jinju Han; Ahmet M Denli; Fred H Gage
Journal:  Genes Dev       Date:  2012-01-01       Impact factor: 11.361

6.  The long and short of microRNAs in the kidney.

Authors:  Jacqueline Ho; Jordan A Kreidberg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

7.  Pri-miR-17-92a transcript folds into a tertiary structure and autoregulates its processing.

Authors:  Saikat Chakraborty; Shabana Mehtab; Anand Patwardhan; Yamuna Krishnan
Journal:  RNA       Date:  2012-03-26       Impact factor: 4.942

8.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells.

Authors:  Yun Lu; J Michael Thomson; Ho Yuen Frank Wong; Scott M Hammond; Brigid L M Hogan
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

9.  A simple high-throughput technology enables gain-of-function screening of human microRNAs.

Authors:  Wen-Chih Cheng; Tami J Kingsbury; Sarah J Wheelan; Curt I Civin
Journal:  Biotechniques       Date:  2013-02       Impact factor: 1.993

10.  MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.

Authors:  Nuo Yang; Sippy Kaur; Stefano Volinia; Joel Greshock; Heini Lassus; Kosei Hasegawa; Shun Liang; Arto Leminen; Shan Deng; Lori Smith; Cameron N Johnstone; Xian-Ming Chen; Chang-Gong Liu; Qihong Huang; Dionyssios Katsaros; George Adrian Calin; Barbara L Weber; Ralf Bützow; Carlo M Croce; George Coukos; Lin Zhang
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.